AIM
Aim Immunotech Inc.
$0.53+0.01 (1.92%)
Price
MA20
▲Insider buy
▼Insider sell
Loading chart...
🤖 AI InsightHaiku 4.5
AIM ImmunoTech Inc. (AIM) is a publicly traded company with 5 insider transactions disclosed via SEC Form 4 in the past 90 days, involving 2 unique insiders. All data below is sourced directly from public SEC EDGAR Form 4 filings.
Latest Insider Transactions
7 transactions (past 365 days)
| 1WStock price change 1 week after insider bought. Small number below shows return vs S&P 500. | 1MStock price change 1 month after insider bought. | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2026-03-16 | 2026-03-12 | Equels Thomas K | CEO | Conversion | 25,000 | $0.00 | $0 | N/A | N/A |
| 2026-03-16 | 2026-03-12 | Chemerow David I. | Director | Conversion | 25,000 | $0.00 | $0 | N/A | N/A |
| 2026-03-10 | 2026-03-06 | Equels Thomas K | CEO | Other | 50,000 | $1.00 | $50,000 | N/A | N/A |
| 2026-03-10 | 2026-03-06 | Chemerow David I. | Director | Other | 50,000 | $1.00 | $50,000 | N/A | N/A |
| 2026-02-06 | 2026-02-05 | Chemerow David I. | Director | Award | 2,800 | $1.23 | $3,444 | N/A | N/A |
| 2025-06-16 | 2025-06-13 | Equels Thomas K | CEO | Purchase | 107 | $7.70 | $824 | N/A | N/A |
| 2025-06-13 | 2025-06-12 | Equels Thomas K | CEO | Purchase | 103 | $8.70 | $896 | N/A | N/A |